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IT IS well-established that damaged articular 
cartilage has only a limited ability to repair itself 
[1]. Recently, Brittburg et al. reported the 
treatment of full-thickness articular defects in the 
human knee by transplantation of cultured 
autologous chondrocytes [2]. This work was an 
extension of animal studies involving the trans- 
plantation of chondrocytes or their progenitors 
into similar defects [3-11]. However, the success of 
all of these techniques has been variable, and 
limited in that none were able to demonstrate 
long-term repair of the damaged cartilage with 
tissue that was histologically, biochemically, and 
biomechanically identical to normal cartilage. 
Several cytokines, including transforming 
growth factor ~-1 (TGF-~I) and insulin-like growth 
factor-1 (IGF-1), have been found to play signifi- 
cant roles in promoting chondrocyte anabolism 
and inhibiting chondrocyte catabolism (reviewed 
in [12]). Thus, the presence of one or more of these 
cytokines during repair  may be the key to 
regenerating normal cartilage [3]. However, sus- 
tained delivery of sufficient quantities of a 
cytokine(s) to  transplanted cells bound within a 
three-dimensional matrix would be difficult and 
impractical using conventional methods. 
Gene therapy offers an elegant solution to this 
delivery problem [13]. By introducing an exogen- 
ous gene(s) into cells prior to transplantation, a 
therapeutic cytokine(s) may be expressed in vivo at 
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high levels for an extended period of time. The 
local production of repair factors in this manner 
may produce a better biological effect than when 
these factors are added exogenously. Here we show 
that rabbit articular chondrocytes can be retrovi- 
rally transduced to express exogenous genes 
(transgenes) in vitro, and that when incorporated 
into type I collagen gels and allografted into 
full-thickness articular cartilage defects in rabbits, 
these cells are able to express a transgene in vivo 
for at least 4 weeks. 
Methods  
Articular chondrocytes (AC) were isolated from 
articular cartilage harvested from the shoulders 
and knees of euthanized 3-month-old New Zealand 
white rabbits (Green Meadows Rabbitry, Mur- 
rysville, PA, U.S.A.) using the method of Green 
[10]. AC were then grown in monolayer culture in 
F-12 nutrient medium (Gibco BRL, Grand Island, 
NY, U.S.A.) supplemented with 10% fetal bovine 
serum (Gibco BRL) and 1% penicillin-strepto- 
mycin (Gibco BRL) at 37°C in an atmosphere of5% 
CO2. Cells were subcultured at a 1:3 split ratio. 
Passage 1 AC were infected with BAG, a 
r~troviral vector containing cDNA encoding 
~-galactosidase (lacZ) and neomycin phosphotrans- 
ferase (neo r) [14]. Media were decanted from T-25 
flasks containing adherent AC at approximately 
70% confluence after which 1 ml BAG retroviral 
vector suspension (titer: 1 x 106 cfu/ml) containing 
8 pg/ml Polybrene (Sigma, St. Louis, MO, U.S.A.) 
was layered onto the cells. The cells were 
incubated for 2 h at 37°C in an atmosphere of 5% 
CO2 with gentle swirling of the vector suspension 
every 20 min. After this incubation period, 3 ml 
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fresh medium was added to each flask and the 
cultures returned to the incubator. 
To select for transduced AC expressing 
neomycin phosphotransferase, the produce of the 
neo r transgene, freshly split cells were placed into 
medium containing I mg/ml G418 (Gibco BRL), a 
synthetic neomycin analog. G418 is toxic to cells 
that do not express the transgene. The transduced, 
G418 selected AC were allowed to grow to 
confluence. To assess expression of ~-galactosi- 
dase, the product of the lacZ transgene, some of 
these cultures were stained with 0.1% X-gal 
(5-bromo-4-chloro-3-indolyl- ~-D-galactopyanoside, 
Sigma) using standard methods [14]. Cells which 
express the lacZ transgene are stained blue on 
exposure to this chromogenic substrate for 
~-galactosidase. 
Other transduced, G418 selected AC cultures, as 
well as untransduced AC cultures, were 
trypsinized (0.25% trypsin, Gibco BRL), washed 
(Gey's balanced salt solution, Gibco BRL), and 
incorporated into bovine type I collagen gels (CG) 
(Vitrogen 100, Celtrix, Santa Clara, CA, U.S.A.) at 
a concentration of 2x10 ~ cells/ml according to 
Celtrix instructions. The cell suspension was 
aliquoted into sterile microfuge tubes (0.5 ml/tube) 
and incubated for 30 min at 37°C to allow the 
collagen to gel. 
Under aseptic conditions, bilateral knee arthro- 
timies were performed on anesthetized 3-month-old 
New Zealand white rabbits using the medial 
parapatellar approach. A nitrogen gas driven drill 
with a 1.5 mm burr under constant saline irrigation 
was then used to create a 3 x 3 x 6 mm full-thickness 
articular cartilage defect in both medial femoral 
condyles. AC/CG were evacuated from microfuge 
tubes and cut to appropriate size for allotransplan- 
tation. Left knees received transduced AC/CG and 
right knees received untransduced control AC/CG. 
Fibrin sealant (kind gift of Martin McPhee, Ph.D., 
American Red Cross, Rockville, MD, U.S.A.) was 
used to fix the AC/CG into the defects. A drop of 
fibrinogen solution was placed into the defect hus 
coating the cut surfaces of the cartilage and 
subchondral bonei excess solution was blotted off 
with sterile filter paper. The AC/CG was coated 
with thrombin solution in a similar fashion. 
Treated in this manner, the AC/CG, when placed 
into the defect, was immediately adherent. The 
incision was then closed in two layers (synovium/ 
joint capsule and skin). Animals were allowed free 
cage activity after surgery. Six rabbits per group 
were used for each time point. 
Rabbits were killed at either 1, 2 or 4 weeks after 
transplantation, and AC/CG were recovered from 
the defects by sharp excision. Some o f  the 
recovered AC/CG were minced into approximately 
1 mm pieces and placed into explant culture. Cells 
then migrated out of the CG, adhered to the 
plastic, and grew to confluence, at which time they 
were stained with X-gal. Other AC/CG were placed 
into Tissue Tek OCT compound (Miles, Elkhart, 
IN, U.S.A.), snap frozen w i th  Histofreeze-2000 
(Fisher Scientific, Pittsburgh, PA, U.S.A.), cryosec- 
tioned (5-gm thickness), and stained with X-gal. 
Some of these sections were counterstained with 
0:1% nuclear fast red (Poly Scientific, Bay Short, 
NY, U.S.A.) to assess the overall cellularity of 
theAC/CG. 
Resu l ts /D iscuss ion  
The first step in assessing the feasibility of ex 
vivo gene therapy for full-thickness articular 
cartilage defects was to determine whether 
exogenous genes could be introduced into, and 
expressed by, AC. At~ter in vitro infection with the 
BAG retroviral vector, we were able to select a 
population of AC resistant o the toxic effects of 
G418. Further, approximately 80% of these cells 
were also stained blue by X-gal (Fig. 1). At this 
stage, the cells retained t~he flattened, polygonal 
morphology that is typical,of early passage AC in 
monolayer culture. 
To test viability and length of transgene 
expression of transduced AC in vivo, BAG infected 
and G418 Selected AC were incorporated into 
bovine type I collagen gels and transplanted into 
large full-thickness articular cartilage defects 
created in the medial femoral condyles of rabbits. 
Rabbits were killed 1, 2 or 4 weeks after 
transplantation. Gross, visual observation of the 
operated areas revealed that the fibrin sealant was 
intact, and that the transferred material had 
remained within the defects. The AC/CG were then 
removed and analyzed by  X-gal staining after 
either explant culture or frozen section. Histologi- 
cal examination confirmed that the transplanted 
material had remained in place. AC cultured from 
the transduced AC/CG recovered after 1 and 2 
weeks, but not 4 weeks in vivo demonstrated 
positive X-gal staining although the cells ex- 
pressed a fibroblastic morphology under these 
explant conditions [Fig 2(a) and (b)]. AC cultured 
from untransduced AC/CG did not demonstrate 
positive X-gal staining at any of the time points. 
Frozen sections of transduced AC/CG demon- 
strated X-gal positive cells after 1, 2 and 4 weeks 
in vivo [Figs 3(a), (b), and (c)]. The distribution of 
cells within the transplanted area was not uniform, 
but patchy. This may reflect clumping of the cells 
before transfer into the defect, or alternatively, 
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FIG. 1. Rabbit articular chondrocytes in monoloayer 
culture after infection with BAG retrovirus, election in 
G418, and staining with X-gal. 
may reflect differential survival of cells depending 
on their physical location. As determined by 
nuclear fast red counterstaining, however, the 
proportion of X-gal positive cells decreased with 
time from approximately 10% staining blue at 1 
week to less than 5% staining blue at 4 weeks; the 
total number of cells in the defect did not appear 
to decline. However, precise quantitation ofLac Z ÷ 
cells was not possible because of their uneven 
distribution. These cells had the rounded shape of 
ehondrocytes uggesting that the fibroblastic 
morphology seen in explant culture was a result of 
the culture procedure. However, biochemical 
markers of chondrocyte differentiation were not 
employed. None of the frozen sections of untrans- 
duced AC/CG contained X-gal positive cells at any 
of the time points. 
Here we have shown that rabbit AC are 
susceptible to in vitro retrovirally mediated gene 
transfer, and that transgene xpression persists for 
at least 4 weeks following al lotransplantation f 
the AC into full-thickness articular cartilage 
defects. Transfer of an appropriate therapeutic 
gene or genes into such defects using this 
technique may allow better repair by one of two 
routes. In the first scenario, expression of the 
therapeutic gene(s) could act in an autocrine and 
paracrine fashion to facilitate expression of the 
appropriate functional ehondrocytic phenotype by 
the transplanted cells; these chondrocytes would 
then have the ability to regenerate new articular 
cartilage. In the second scenario, the transplanted 
ehondroeytes act as a biological cytokine delivery 
system which toeally generates cytokines that 
stimulate the migration, proliferation, and differ- 
entiation of ehondroeytic progenitor cells originat- 
ing from subchondral bone marrow which then 
regenerate new articular cartilage. According to 
Fro. 2. X-gal staining of chondrocytes at confluence after 
surgical recovery from the knee and reculture in vitro. 
(a) BAG transduced chondrocytes after 1 week in vivo (b) 
BAG transduced chondrocytes after 2 weeks in vivo. No 
lacZ positive cells were cultured from gels after 4 weeks 
in vivo. 
this strategy the transduced, transplanted cells 
need not be chondrogenic. 
In this study, the number of cells expressing the 
transgene falls with time in vivo. This may reflect 
(1) loss of transgene xpression, (2) dilution of the 
transplanted transduced AC by host bone marrow 
mesenchymal cells migrating into the defect, (3) 
death of the allogeneic transduced AC secondary 
to a cytotoxic immune response, (4) death resulting 
from trauma of cell culture and transplantation, or 
(5) programmed cell death. The present data do not 
distinguish between these possibilities. 
Prolonged high expression of a therapeutic 
transgene in this approach to repairing cartilagi- 
nous defects may not be necessary or desirable. 
Continued st imulat ion of cartilage matrix for- 
mation could, for instance, lead to focal hyper- 
plasia of the cartilage with loss of articular surface 
congruity and subsequent degeneration. There is 
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developed here will permit testing of candidate 
factors in a manner which is difficult to attain by 
tradit ional methods. TGF-~I, IGF-1, and BMP-2 
have obvious advantages as possible chon- 
droreparative factors. 
Having successfully combined the existing 
techniques of chondrocyte transplantat ion with 
the novel possibilities offered by modern gene 
transfer technology, we have produced an innova- 
tive technique with which to address the problem 
of carti lage repair. Using this technique, we have 
a powerful new tool with which (1) to test the role 
of cytokine mediators in art icular cartilage repair 
and (2) to use the knowledge thus gained to effect 
a better repair of full-thickness articular carti lage 
defects that occur as a result of arthrit is and 
injury. 
FIG. 3. X-gal staining of 5 ~m sections of a type I collagen 
gel containing BAG transduced chondrocytes. (a) After 
1 week in vivo (b) After 2 weeks in vivo (c) After 4 weeks 
in vivo. 
also the additional concern that excessive pro- 
duction of chondrogenic factors promotes the 
formation of osteophytes [15]. Further studies are 
needed to determine the optimum time of required 
gene expression. 
The above discussion begs the question of which 
transgene or combination of transgenes best 
facilitates the repair of full-thickness art icular 
carti lage defects. At this time, the answer is 
unknown. The experimental system we have 
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